|
|
 |
|
Viewing report
|
|
|
|
US Hemostasis Market
Venture Planning Group, Aug 2011, Pages: 424
This comprehensive country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the hemostasis diagnostics market during this decade.
The report explores business and technological trend; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the hemostasis diagnostics practice during the next ten years.
New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Hemostasis testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the hemostasis testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Each Country Report provides the following information:
- Sales and market shares of major instrument and reagent suppliers.
- Strategic profiles of leading competitors and emerging market entrants.
- Comprehensive market segmentation analysis.
- Forecasts for over 40 procedures, by country and market segment.
- Review of emerging tests.
- Comparison of over 50 automated and semi-automated analyzers.
- Analysis of innovative technologies.
- Estimates of facilities performing hemostasis tests by country.
- Product development and business expansion opportunities.
- Alternative market penetration strategies.
Highlights:
- Comprehensive 424-page analysis of the US hemostasis market.
- Major issues pertaining to the US hemostasis laboratory practice, as well as during the next ten years.
- Ten-year volume and sales forecasts for 40 hemostasis procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads.
- Placement estimates for major automated and semi-automated systems.
- Review of current instrumentation technologies, and a feature comparison of nearly 50 leading analyzers.
- Ten-year reagent and instrument sales forecasts.
- Sales and market shares of leading reagent and instrument suppliers.
- Review of hemostasis technologies and their potential market applications.
- Major opportunities for coagulation instruments and consumables.
- Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 424 pages and 18 tables
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, and Venture Planning Group's proprietary data files was conducted.
Also available
Global Hemostasis Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
|
|
|
|
